A fluorinated aza-BODIPY derivative for NIR fluorescence/PA/F MR tri-modality in vivo imaging.

Chem Commun (Camb)

State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences, Wuhan National Laboratory for Optoelectronics, Wuhan 430071, China.

Published: May 2019

AI Article Synopsis

  • A new fluorinated aza-BODIPY compound, named BDPF, was created to serve as a contrast agent for imaging.
  • It demonstrated effective imaging capabilities in three modalities: near-infrared fluorescence, photoacoustic imaging, and fluorine-19 magnetic resonance (MR) imaging.
  • This tri-modal approach provides a comprehensive tool for tumor imaging, enhancing diagnostic accuracy.

Article Abstract

A fluorinated aza-BODIPY derivative BDPF was developed as a small molecule contrast agent, which displayed highly efficient near infrared fluorescence/photoacoustic/19F MR tri-modality tumor imaging.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c9cc01253bDOI Listing

Publication Analysis

Top Keywords

fluorinated aza-bodipy
8
aza-bodipy derivative
8
derivative nir
4
nir fluorescence/pa/f
4
fluorescence/pa/f tri-modality
4
tri-modality vivo
4
vivo imaging
4
imaging fluorinated
4
derivative bdpf
4
bdpf developed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!